Genotyping studies from 169 patients with INSS stage 4 NB undergoing hematopoietic stem cell transplantation showed that patients with the phenotype lacking MHC class I ligands for autologous inhibitory KIR were associated with better clinical outcomes. Here, KIR3DL1 is linked to neuroblastoma.